Status:
UNKNOWN
Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.
Lead Sponsor:
University Hospital, Lille
Conditions:
Phenylketonurias
Eligibility:
All Genders
18+ years
Brief Summary
You were detected during the neonatal period for phenylketonuria and you benefited from the diagnosis of an adapted dietetic care, and this for a variable duration according to the recommendations fol...
Eligibility Criteria
Inclusion
- Patients with classic or atypical phenylketonuria detected in the neonatal period since 1971 in the department of Nord (59) and Pas de Calais (62).
- Patients treated
- Able to receive information
- Patient beneficiary or affiliated to a social security
Exclusion
- Patients not screened (born outside French territory) or before 1971.
- Untreated screened patients
- Patients screened for persistent benign hyperphenylalaninaemia not treated with a diet (Phenylalanine level \<10 mg / dl or 600 µmol / l without diet to be confirmed)
- Associated confirmed neurological pathology other than a complication of phenylketonuria.
- Refusal to participate in the assessment of Intellectual Quotient in adulthood
- Patient screened, lost to follow-up, found, having moved to another region and not wishing to return to the CHU for follow-up.
- Inability to receive information and or express opposition
- Opposition to participation in the study
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04433728
Start Date
September 1 2022
End Date
September 1 2024
Last Update
March 17 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.